Who should avoid glutathione
Understanding this journey is not merely a pharmacokinetic exercise but is fundamental to explaining the disparate outcomes observed in clinical trials and for designing precision-based interventions
Retatrutide and growth hormone peptides Research on combining metabolic peptides with growth hormone secretagogues like ipamorelin or CJC-1295 is limited but growing
Expanding application scope to explore interventions in aging-related diseases (neurodegenerative diseases, cardiovascular diseases, metabolic diseases), providing new strategies for their prevention and treatment
Recommended dosing of 1-2 mg subcutaneous injection 2-3x per week (6 mg/week total) compares to toxic dose estimated at ~22,500 mg (approximately 3,750 times higher than weekly dose)
Pre-operative redox state affects 1-month survival in patients with advanced heart failure undergoing left ventricular assist device implantation